Skip to Main Content

Paper Details

Phase II Study of ENZAlutamide Combined With Hypofractionated Radiation Therapy (ENZART) for Localized Intermediate Risk Prostate Cancer.
Front Oncol
1
2022
Author NameAffiliation
Xavier MaldonadoVall d'Hebron University Hospital
  • 1 - 1

Datasets

Release 1.2